Skip to main content
. 2016 Jul 19;17:86. doi: 10.1186/s12931-016-0405-9

Table 2.

DAVID Functional Annotation Charts, 2-h and 18-h Severe PE verses Vehicle

Category Term a2-h Severe PE verses Vehicle 18-h Severe PE verses Vehicle
Ct % Dir Fold B&H Ct % Dir Fold B&H
SP_PIR acetylation 183 17.72 UP 1.86 0.000
SP_PIR activator 7 7.29 UP 5.58 0.025
SP_PIR acute phase 7 0.68 UP 4.89 0.047
rno00520 Amino sugar and nucleotide
sugar metabolism
12 1.16 UP 4.37 0.002
rno00970 Aminoacyl-tRNA biosynthesis 12 1.16 UP 4.70 0.002
SP_PIR Aminoacyl-tRNA synthetase 10 0.97 UP 5.11 0.003
rno00330 Arginine and proline metabolism 11 1.06 UP 3.25 0.046
rno05412 Arrhythmogenic right ventricular
cardiomyopathy (ARVC)
15 0.96 D 2.56 0.040
rno05217 Basal cell carcinoma 12 0.77 D 2.97 0.036
IPR011700 Basic leucine zipper 4 4.17 UP 41.80 0.004
IPR004827 Basic-leucine zipper (bZIP) transcription factor 8 8.33 UP 28.54 0.000
SM00338 BRLZ 8 8.33 UP 20.66 0.000
IPR011616 bZIP transcription factor, bZIP-1 4 4.17 UP 25.44 0.015
SP_PIR Chaperone 18 1.74 UP 2.78 0.006
SP_PIR chemotaxis 4 4.17 UP 20.78 0.025 9 0.87 UP 4.43 0.016
SP_PIR Cholesterol biosynthesis 9 0.87 UP 7.47 0.000
rno04610 Complement and coagulation cascades 17 1.65 UP 3.80 0.000
SP_PIR cytokine 9 9.38 UP 15.21 0.000
SP_PIR DNA binding 6 6.25 UP 7.38 0.028
SP_PIR dna-binding 15 15.63 UP 3.75 0.002
UP_SEQ DNA-binding region: Basic motif 10 10.42 UP 15.44 0.000
UP_SEQ domain: Leucine-zipper 9 9.38 UP 19.96 0.000
rno00982 Drug metabolism 20 1.28 D 3.51 0.000
rno04512 ECM-receptor interaction 17 1.09 D 2.65 0.020
SM00180 EGF_Lam 9 0.58 D 5.44 0.020
IPR002049 EGF-like, laminin 9 0.58 D 5.98 0.026
SP_PIR endoplasmic reticulum 63 6.10 UP 2.04 0.000
PIRSF001719 fos transforming protein 4 4.17 UP 109.2 0.000
IPR000837 Fos transforming protein 4 4.17 UP 83.59 0.001
rno00480 Glutathione metabolism 12 0.77 D 3.03 0.041
rno00340 Histidine metabolism 9 0.58 D 4.73 0.019
SP_PIR inflammatory response 4 4.17 UP 16.51 0.027 13 1.26 UP 5.08 0.000
SP_PIR Initiation factor 12 1.16 UP 4.55 0.002
SP_PIR Isomerase 17 1.65 UP 3.14 0.003
SP_PIR lipid synthesis 19 1.84 UP 3.82 0.000
rno00980 Metabolism of xenobiotics by cyt. P450 18 1.15 D 3.79 0.000
UP_SEQ mutagenesis site 59 3.77 D 1.75 0.042
rno04621 NOD-like receptor signaling pathway 5 5.21 UP 12.52 0.034
SP_PIR nucleotide-binding 99 9.58 UP 1.36 0.024
SP_PIR nucleus 22 22.92 UP 2.01 0.026
SP_PIR phosphoprotein ## 27.49 UP 1.24 0.000
IPR011993 Pleckstrin homology-type 32 2.05 D 2.27 0.027
SP_PIR protein biosynthesis 22 2.13 UP 2.04 0.049
SP_PIR protein transport 34 3.29 UP 1.87 0.016
SP_PIR Redox-active center 10 0.97 UP 4.74 0.005
SP_PIR ribosome biogenesis 8 0.77 UP 5.31 0.014
SP_PIR rna-binding 33 3.19 UP 2.16 0.002
SM00360 RRM 21 2.03 UP 2.69 0.015
SM00199 SCY 5 5.21 UP 18.26 0.003
IPR001811 Small chemokine, interleukin-8-like 5 5.21 UP 25.22 0.002
SP_PIR Steroid biosynthesis 13 1.26 UP 5.08 0.000
rno00100 Steroid biosynthesis 9 0.87 UP 8.29 0.001
SP_PIR sterol biosynthesis 11 1.06 UP 7.31 0.000
SP_PIR Transcription 14 14.58 UP 3.23 0.009
SP_PIR transcription regulation 14 14.58 UP 3.48 0.006
SP_PIR translocation 11 1.06 UP 3.75 0.014
rno00350 Tyrosine metabolism 10 0.64 D 3.71 0.032

Functional annotations significantly over-represented in the lists of up-regulated and down- regulated genes during 2-h and 18-h High-PE. Annotations unique to High-PE are highlighted in bold italics; annotations common to High-PE and Low-PE (Table 1) are in standard font. All other keys are the same as in Table 1. aNo 2-h DOWN annotations meet B&H < 0.05